--- title: "India's TB Strategy: AI and Molecular Testing" description: "India is overhauling tuberculosis detection with AI tools and molecular testing, a shift that could reshape global health and accelerate the fight against TB." url: "https://modeldiplomat.com/story/indias-tb-strategy-transitions-to-ai-and-molecular-testing" --- # India's TB Strategy: AI and Molecular Testing A shift in tuberculosis detection methods in India Model DiplomatApril 30, 20263 min readAsia [Aruna BhattacharyaWhat tuberculosis reveals about India’s urban health systems - The Hindu](https://www.thehindu.com/opinion/op-ed/what-tuberculosis-reveals-about-indias-urban-health-systems/article70830450.ece)[The Hindu BureauExperts discuss the future of India’s diagnostic innovation at National Diagnostics Conclave - The Hindu](https://www.thehindu.com/news/cities/bangalore/experts-discuss-the-future-of-indias-diagnostic-innovation-at-national-diagnostics-conclave/article70884718.ece)[Soibam Rocky SinghTB patients without documents miss aid - The Hindu](https://www.thehindu.com/news/cities/Delhi/tb-patients-without-documents-miss-aid/article70909542.ece) ## India’s TB Fight Is Shifting to AI and Molecular Tests *WHO-backed near-point-of-care tests and India’s rollout are moving TB detection out of labs. The bottleneck is now last-mile follow-through.* India’s tuberculosis strategy is moving from a lab-centered model to a field-centered one. The immediate trigger is technical, but the power shift is administrative: **WHO’s 2026 backing for near point-of-care molecular TB tests, including tongue swabs and sputum pooling, strengthens New Delhi’s hand to push diagnosis closer to the patient and away from older smear-microscopy workflows**. In her latest *The Hindu* lead essay, **Soumya Swaminathan** argues India has already spent a decade shifting from sputum smear microscopy to **CBNAAT and Truenat**, while adding **portable chest X-rays with AI** to community screening under the national TB campaign. [The evolving diagnostic landscape for tuberculosis](https://www.thehindu.com/opinion/lead/the-evolving-diagnostic-landscape-for-tuberculosis/article70776514.ece "thehindu.com") ## Why the shift matters This is not just a medical upgrade. It is a control issue. **India still accounts for roughly 25% of global TB cases and 32% of global multidrug- or rifampicin-resistant TB cases**, so faster diagnosis in India changes the global TB picture more than reforms almost anywhere else. India’s incidence has fallen **21% since 2015**, but its absolute burden remains the largest in the world. [Swing, but do not miss: on India and the WHO’s Global Tuberculosis Report 2025](https://www.thehindu.com/opinion/editorial/swing-but-do-not-miss-on-india-and-the-whos-global-tuberculosis-report-2025/article70287469.ece "thehindu.com") The winners from this transition are clear. **The National TB Elimination Programme**, state health departments, and manufacturers of rapid molecular platforms gain leverage because they can compress the diagnostic chain from weeks to hours. Karnataka’s health system, for example, says **CBNAAT can detect TB and rifampicin resistance in about two hours**, versus weeks for culture-based testing, and the state ran **1.10 million molecular tests in 2025**. [KC General Hospital gets advanced CBNAAT machine to speed up TB diagnosis](https://www.thehindu.com/news/national/karnataka/kc-general-hospital-gets-advanced-cbnaat-machine-to-speed-up-tb-diagnosis/article70358154.ece "thehindu.com") For policymakers tracking [India](https://modeldiplomat.com/discover/india "modeldiplomat.com") and wider [International Affairs](https://modeldiplomat.com/discover/international "modeldiplomat.com"), the implication is straightforward: **diagnostics are becoming the main instrument of TB governance**, because whoever controls screening protocols, device procurement, and sample transport increasingly controls who gets counted, treated, and funded. ## Where the system still breaks The constraint is no longer only technology. It is execution. Swaminathan notes that **up-front universal NAAT coverage remains uneven**, especially where sputum collection, transport, and outreach are weak for elderly, disabled, rural, and tribal populations. AI-enabled X-rays can widen the net, but they do not close the case unless sample collection happens immediately. [The evolving diagnostic landscape for tuberculosis](https://www.thehindu.com/opinion/lead/the-evolving-diagnostic-landscape-for-tuberculosis/article70776514.ece "thehindu.com") State rollouts show both the promise and the limit. Andhra Pradesh is deploying **100 AI-enabled handheld X-ray machines** at a cost of about **₹20 crore**; the machines produce images in **30 seconds** and AI reports in roughly **two minutes**. But patients flagged by AI still need sputum testing to confirm disease. [AI-enabled X-ray machines to increase TB surveillance in State](https://www.thehindu.com/news/national/andhra-pradesh/ai-enabled-x-ray-machines-to-increase-tb-surveillance-in-state/article70780949.ece "thehindu.com") ## What to watch next Watch **whether WHO’s 2026 recommendations become Indian procurement rules**, not just expert talking points. The next real test is whether New Delhi and the states standardize **same-day molecular confirmation after AI chest X-ray screening**, and whether newer tools such as **tongue-swab testing** move from guidance into routine use. If that happens in 2026, microscopy stops being the backbone of TB detection in India and becomes the fallback. [Tuberculosis](https://modeldiplomat.com/tag/tuberculosis)[AI](https://modeldiplomat.com/tag/ai)[Healthcare](https://modeldiplomat.com/tag/healthcare)[India](https://modeldiplomat.com/tag/india)[Molecular Testing](https://modeldiplomat.com/tag/molecular-testing) Discover more [India](https://modeldiplomat.com/story/india-and-south-korea-aim-for-50-billion-trade-expansion) #### [India-South Korea $50B Trade Expansion Plan](https://modeldiplomat.com/story/india-and-south-korea-aim-for-50-billion-trade-expansion) [India and South Korea target $50 billion in bilateral trade by 2030, focusing on industrial cooperation and strategic alignment amid US pressures.](https://modeldiplomat.com/story/india-and-south-korea-aim-for-50-billion-trade-expansion) [India](https://modeldiplomat.com/story/cpim-pushes-to-decouple-quota-policy-from-delimitation-in-india) #### [CPI(M) Calls to Decouple Quota from Delimita](https://modeldiplomat.com/story/cpim-pushes-to-decouple-quota-policy-from-delimitation-in-india) [CPI(M) advocates for a 33% women's quota in Lok Sabha by 2029, removing the need for delimitation and census linkage.](https://modeldiplomat.com/story/cpim-pushes-to-decouple-quota-policy-from-delimitation-in-india) [Economics](https://modeldiplomat.com/story/feds-amex-aml-order-puts-correspondent-banking-on-notice) #### [Fed's Amex AML order puts correspondent banking on notice](https://modeldiplomat.com/story/feds-amex-aml-order-puts-correspondent-banking-on-notice) [Federal Reserve's Amex AML order requires board-level controls and a 90-day plan; OCC fined the bank $350 million over enterprise-wide deficiencies.](https://modeldiplomat.com/story/feds-amex-aml-order-puts-correspondent-banking-on-notice) [Conflict & Security](https://modeldiplomat.com/story/guatemala-el-ni%C3%B1o-202627-becomes-regional-security-test) #### [Guatemala: El Niño 2026–27 becomes regional security test](https://modeldiplomat.com/story/guatemala-el-ni%C3%B1o-202627-becomes-regional-security-test) [UNICEF: 25.8M children face El Niño risks in Latin America; Guatemala maps 188 municipalities for drought and food insecurity amid regional security test.](https://modeldiplomat.com/story/guatemala-el-ni%C3%B1o-202627-becomes-regional-security-test)